SLC5A2 and myocardial infarction: SGLT-2 inhibitors also help rebalance intracellular sodium and calcium levels in cardiomyocytes, supporting improved left ventricular systolic function post-myocardial infarction and mitigating calcium overload caused by doxorubicin.